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secondary sexual traits that develop under the action of testosterone, such as masculine 
human male facial characteristics, have been proposed to signal the strength of the immune 
system due to the sex hormone’s immunosuppressive action. Recent work has suggested that 
glucocorticoid stress hormones may also influence expression of such sexual signals due to 
their effects on immune function. Precise roles, however, remain unclear. Here we show positive 
relationships between testosterone, facial attractiveness and immune function (antibody 
response to a hepatitis B vaccine) in human males, and present some preliminary evidence 
that these relationships are moderated by naturally co-occurring cortisol (a glucocorticoid 
stress hormone involved in the fight-or-flight response). We conclude that our results provide 
support for a role of glucocorticoids in hormonally mediated sexual selection. 
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Testosterone-dependent traits have been proposed to provide an honest signal of male immune function due to the sex hormone’s immunosuppressive effects1. A review of cross-
species data, however, has demonstrated inconsistent effects of tes-
tosterone (T) on immune function2, and glucocorticoids have been 
proposed to contribue to this complexity3,4. These stress hormones 
modulate the immune system5 and expression of secondary sexual 
traits6, and they may interact with T in effects on both7–9. Precise 
roles in sexual selection, however, remain unclear due to the reli-
ance of extant tests on artificial elevation of T, such that interactions 
with glucocorticoids may result from the stressful implantation 
procedure or from T levels elevated beyond an individual’s natural 
range7. Sexually dimorphic characteristics in the human male face 
are T-dependent10,11, and female preferences for these have been 
interpreted as a strategy to secure heritable immunocompetence 
for offspring12,13.
Here we demonstrate positive relationships between T, facial 
attractiveness and immune response to a hepatitis B vaccine, and 
present some evidence that these relationships are moderated by 
naturally co-occurring cortisol (C). Our results are the first to show 
that human female face preferences are correlated directly with a 
measure of male immune function, and to provide some prelimi-
nary evidence of a possible moderating role of glucocorticoids in 
relationships between T, secondary sexual trait expression and 
immune function. We anticipate that our findings will provide a 
platform for the development of a more powerful model of hormo-
nally mediated sexual selection that incorporates specific functions 
of glucocorticoids.
Results
Sample characteristics. A total of 74 males (age: 23.12 (3.89)) 
were recruited from the University, and Transportation College, 
of Daugavpils, Latvia. Use of human subjects complied with the 
regulations of the University of Daugavpils and the Declaration 
of Helsinki. We assessed T, C and anti-hepatitis B surface antigen 
(anti-HBsAg) levels from 10 ml of venous blood collected between 
0900 and 1100 h, approximately 30 min before and 1 month 
after the first dose of a hepatitis B vaccine. Anti-HBsAg, T and 
C were measured using commercially available immunoassays. 
No participant expressed anti-HBsAg before vaccination (post-
vaccination: 9.53 (13.68) mIU ml − 1), 16 participants (21.6%) did 
not produce antibodies (non-seroconverters; levels consistent with 
previous research14) and 27 participants (36.5%) were seroprotected 
(produced ≥10 mIU ml − 1 of anti-HBsAg). T levels were attained for 
all participants (10.68 (2.85) nmol l − 1), and C levels were attained 
for a sub-sample of 62 participants (463.43 (152.28) nmol l − 1). 
T and C showed strong consistency across samples (intraclass 
correlation coefficients (3, 1) were 0.81 and 0.91, respectively), 
so we calculated means for each participant. Facial photographs 
were collected under standardized lighting conditions with neutral 
expression, normalized on interpupillary distance and rated by 94 
female students of the University of Daugavpils (age: 20 (1.89)) 
from  − 5 (very unattractive) to  + 5 (very attractive). Inter-rater 
reliability was high (Cronbach’s alpha = 0.97), so we computed the 
mean attractiveness scores for each male participant.
Relationships between T, C, anti-HBsAg and attractiveness. 
A Box–Cox transformation was applied to anti-HBsAg to obtain a 
normal distribution (Kolmogorov–Smirnov: P = 0.057; skewness = 
  − 0.39). There was no significant difference between seroconverters 
(SC) and non-SCs (NSC) in C (SC: 459.3 (157.25) nmol l − 1; NSC: 
477.58 (138.33) nmol l − 1; F(1, 61) = 0.15, P = 0.696, two-tailed), but 
there were significant differences in T (SC: 11.43 (2.63) nmol l − 1; 
NSC: 7.94 (1.75) nmol l − 1; F(1, 73) = 25.1, P < 0.001) and attractive-
ness (SC:  − 1.56 (1.19); NSC:  − 2.58 (0.57); F(1, 73) = 10.83, P = 0.002, 
two-tailed). We therefore conducted all analyses in the full sample 
and the SC sub-sample. We used linear regression models to test 
for bivariate relationships between T, C, a T×C interaction term, 
anti-HBsAg and attractiveness (all two-tailed, Table 1).  T predicted 
attractiveness (full sample: Adj R2 = 0.31, F(1, 73) = 34.08, P < 0.001, 
Fig. 1a; SC: Adj R2 = 0.21, F(1, 57) = 16.2, P < 0.001) and anti-HBsAg 
levels (full sample: Adj R2 = 0.45, F(1, 73) = 61.21, P < .001, Fig. 1b; SC: 
Adj R2 = 0.3, F(1, 57) = 25.38, P < 0.001), such that males with high 
T had higher facial attractiveness ratings and anti-HBsAg levels 
than those with low T. Anti-HBsAg levels predicted attractiveness 
(full sample: Adj R2 = 0.24, F(1, 73) = 23.67, P < 0.001, Fig. 1c; SC: 
Adj R2 = 0.13, F(1, 57) = 9.84, P = 0.003), such that the faces of males 
with a strong immune response to vaccination were perceived as 
more attractive by females than those with a weaker response. The 
T×C interaction term predicted attractiveness and anti-HBsAg 
only in the full sample (attractiveness: Adj R2 = 0.05, F(1, 61) = 4.27, 
P = 0.043, Fig. 1a; SC: Adj R2 = 0.01, F(1, 47) = 1.31, P = 0.259; anti-
HBsAg: Adj R2 = 0.11, F(1, 61) = 8.32, P = 0.005, Fig. 1b; SC: Adj 
R2 = 0.04, F(1, 47) = 3.01, P = 0.089). As T and T×C were significant 
predictors of both attractiveness and anti-HBsAg in the full sample, 
and anti-HBsAg was a significant predictor of attractiveness, mul-
tiple linear regression models were constructed to determine 
whether anti-HBsAg levels mediated relationships between T and 
attractiveness, and T×C and attractiveness. Table 1 shows that anti-
HBsAg mediated the relationship between T×C and attractiveness 
(full sample: Adj R2 = 0.27, F(2, 61) = 12.21, P < 0.001; T×C: β = 0.08, 
P = 0.494; anti-HBsAg: β = 0.51, P < 0.001), but not the relationship 
between T and attractiveness.
Significant relationships in the full sample remained in the SC 
sample, with the exception of T×C with attractiveness and anti-
HBsAg. Furthermore, when anti-HBsAg was dichotomized using a 
median split and entered as the dependent variable in binary logistic 
regression models, T (Nagelkerke R2 = 0.33, Wald = 15.12, P < 0.001, 
Table 1 |  values for the bivariate relationships.
Attractiveness Anti-HBsAg T×C C
T 0.57** (0.47**) 0.68** (0.56**) 0.52** (0.42**)  − 0.18 ( − 0.26)
C  − 0.17 ( − 0.19)  − 0.12 ( − 0.15) 0.71** (0.74**)
T×C 0.26* (0.17) 0.35* (0.25)
Anti-HBsAg 0.5** (0.39**)
T and anti-HBsAg T: 0.43** (0.38*)
Anti-HBsAg: 0.21 (0.18)
T×C and anti-HBsAg T×C: 0.08 (0.05)
Anti-HBsAg: 0.51** (0.47**)
Abbreviations: anti-HbsAg, anti-hepatitis B surface antigen; C, cortisol; T, testosterone.
*P < 0.05, **P < 0.005.
β values for bivariate relationships between T (testosterone; nmol l − 1), C (nmol l − 1), T×C(a testosterone×cortisol interaction term), facial attractiveness and antibody response to a hepatitis B vaccine 
(mIu ml − 1), and for tests of anti-HBsAg as a mediator of relationships between T and attractiveness, and T×C and attractiveness in the full sample and the subsample of participants who produced 
antibodies in response to the vaccine (seroconverters; in parentheses).
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two-tailed) remained as a significant predictor and T×C showed 
a trend towards significance (Nagelkerke R2 = 0.08, Wald = 3.4, 
P = 0.065, two-tailed), and there was a significant difference in 
attractiveness between the two groups (low anti-HBsAg:  − 2.11 
(0.96); high anti-HBsAg:  − 1.45 (1.27); F(1, 72) = 6.51, P = 0.013, 
two-tailed). Two participants received facial attractiveness ratings 
that were above the mean + 2 s.d. (Fig. 1a and c). All significant 
relationships remained when these participants were excluded from 
the analyses, with the exception of that between the T×C interaction 
term and attractiveness (Adj R2 = 0.02, F(1, 60) = 2.22, P = 0.141, 
two-tailed).
Discussion
Our results provide the first evidence that women’s preferences for 
male faces are correlated with male immunocompetence and for a 
consistent interaction between T and C on immune function and 
facial attractiveness. This provides support for a stress-linked ver-
sion of the immunocompetence handicap model of sexual selec-
tion and demonstrates that the role of glucocorticoids was such that 
positive relationships between T and immune response to a vaccine, 
and T and facial attractiveness, were stronger in those males with 
low C. Furthermore, the interaction between T and C in effects on 
attractiveness was mediated by immune function, whereas the rela-
tionship between T and attractiveness was not. This suggests that 
those T-related traits that interact with C are linked to immuno-
competence, but that T may also be related to additional traits that 
contribute to attractiveness such as ability to acquire resources15. 
Although we exert caution in interpreting the positive relationship 
between naturally occurring T and immune function as support 
for an immunocompetence handicap model (it is possible to pre-
dict positive or negative relationships depending upon the quality 
and condition of males in the sample16), our results provide some 
evidence of a moderating role of glucocorticoids in data collected 
using non-invasive techniques that are unlikely to have resulted in 
artificial elevation of T or C.
Glucocorticoids have been proposed to mediate pathways 
between T, immune function and secondary sexual ornamentation4 
(for example, through competition for binding sites17). Lack of con-
sistency in the nature of the relationship between T and glucocorti-
coids7, and our failure to demonstrate such mediation here suggest 
that this is not the case. Our results, instead, suggest a moderating 
role of C, such that the relationships of the immunocompetence 
handicap model of sexual selection may be contingent upon co-
occurring levels of glucocorticoids. This may explain inconsisten-
cies in relationships between T and measures of immune function 
across the samples2. To interpret the interaction between T and C, 
it is necessary to determine whether our measure of morning C is 
a proxy of experience of current stressors18 or individual differ-
ences in traits such as baseline C or dimensions of the physiological 
response to stress. In the former, the effects of T on facial appearance 
and immune function are transient and dependent upon the current 
level of stress experienced by the individual, whereas in the latter, 
there may be an optimal baseline level of C or response to stress that 
bears minimum costs to immune function or sexual signalling7–9. 
Tests of the effects of T on immunity and appearance under periods 
of high and low stress, and identification of the effects of dimensions 
of the C response to a stressor and baseline levels collected from 
multiple points in C’s natural diurnal cycle on the relationships of 
interest, will enable development of a model of specific functions of 
glucocorticoids in sexual selection.
We found T and C to interact in their effects on antibody response 
to a vaccination, such that the positive relationship between T and 
immune response was stronger in males with low C. We found a 
consistent, but weak, interaction between T and C on facial attrac-
tiveness. Facial cues to combinations to T and C may be subtle, 
and more robust relationships may be detected in a larger sample 
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Figure 1 | Relationships between testosterone and antibody levels compared 
with attractiveness. Relationships between testosterone (nmol l − 1) and  
(a) facial attractiveness (n = 74, P < 0.001) and (b) anti-hepatitis B surface 
antigen (mIu ml − 1; Box–Cox transformed; n = 74, P < 0.001) showing 
moderating effects of cortisol (for a subsample of 62 participants for whom 
cortisol measurements were available; bold lines: cortisol below the median; 
broken lines: cortisol above the median) and between (c) anti-hepatitis B 
surface antigen (mIu ml − 1) and facial attractiveness (n = 74, P < 0.001).
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with greater variance or by constructing facial composites that are 
designed to differ in cues to the hormones9. Both relationships 
lost significance when participants who did not produce antibod-
ies were excluded from analyses. Although interactions between 
sex and stress hormones have been reported in previous studies, 
the nature of these results has been inconsistent. Male zebra finch 
(Taeniopygia guttata) with the highest titres of T and corticosterone, 
for example, showed the strongest secondary response to diptheria7, 
whereas no such interaction was found in the Japanese quail 
(Coturnix japonica)19. Such discrepancies may arise from differ-
ences in exposure to stress or socioecological conditions across spe-
cies and samples. Such inconsistency is also evident in tests across 
human societies. In studies conducted in the UK, women typically 
express preferences for the faces of males with cues to low T12,13, and 
an interaction has been shown between T and C on facial attractive-
ness, such that T increases attractiveness in males with high C, but 
decreases attractiveness in those with low C9. The current results 
from a Latvian sample show a positive relationship between T and 
facial attractiveness that was strongest in males with low C. Recent 
research has shown societal level measures of health to influence 
women’s preferences for cues to T in the male face13, meaning that 
societal level factors may underpin differences in the preferences 
of women from the UK and Latvia. Tests of relationships across 
species, societies and contexts will further inform as to the traits 
signalled by combinations of sex and stress hormones. Although 
antibody response to vaccination provides an accurate measure of 
response across the immune system20, future tests should assess dif-
ferent arms of the immune response to evaluate trade-offs between, 
for example, cellular and humoral immunity. In addition, tests 
should be conducted in samples of males at different life stages (for 
example, adolescence and older adulthood) to determine whether 
the relationships reported here are specific to the high T levels 
typical of early adulthood21.
To conclude, our results provide support for the stress-linked 
immunocompetence handicap model of sexual selection. Positive 
relationships between T, immune response to a vaccine, and facial 
attractiveness were stronger in males with low naturally co-occurring 
C, implicating a moderating role of glucocorticoids in hormonally 
mediated sexual selection. The nature of traits that are signaled by 
combinations of sex and stress hormones can be tested by systematic 
investigation of these relationships across species and contexts.
Methods
Hepatitis B vaccine. The hepatitis B vaccine is delivered intramuscularly using a 
three-dose protocol over 6 months and contains hepatitis B surface antigen derived 
from yeast cells. All participants received the Engerix B vaccine manufactured by 
Glaxosmithkline22. Antibody response provides an estimate of total immune func-
tion due to reliance on interactions between multiple arms of the immune  
system20, and response to the hepatitis B vaccine was appropriate because of low 
prior exposure in the target population23 and correlations between antibody 
response to the vaccine, disease resistance24 and psychological measures25.
Levels of anti-HBsAg were assessed at the E. Gulbis Laboratory, Daugavpils, 
Latvia, using an in-house microparticle enzyme immunoassay (AxSYM®, Abbott 
Laboratories) and commercially available kits (AUSAB®, Abbott Laboratories26). 
Blood samples were centrifuged and the separated serum frozen at  − 80 °C until 
analysis. Serum was incubated with microparticles coated with recombinant 
human HBsAg at room temperature for 24 h. The beads were then incubated with 
HBsAg conjugated to biotin and rabbit anti-biotin antibody conjugated with horse-
radish peroxidase, allowing absorbency of control and test samples to be measured. 
Mean intra-assay CV was 2.9%, the lower level of detection was 2 mIU ml − 1 and 
the analytical range was 2–1000 mIU ml − 1. The range of anti-HBsAg in the sample 
was 0–73 mIU ml − 1.
Testosterone. Testosterone was assessed in the same laboratory using an in-house 
competitive chemoluminescent enzyme immunoassay with commercially available 
kits (Immulite® 2000 Total Testosterone27). Serum samples were incubated for 
60 min at 370 °C with an alkaline phosphatase-labeled reagent and polystyrene 
beads coated with polyclonal rabbit antibody. Unbound material was removed by 
centrifugal wash, and bound quantities were measured using a specific chemolumi-
nescent substrate (a phosphate ester of adamantyl dioxetane). Immulite® 2000  
Total Testosterone quality control samples were included to assess the assay  
reliability. Mean intra-assay CV was 9.6%, the method lower limit of detection  
was 0.694 nmol l − 1 (manufacturer’s standard: 0.3 nmol l − 1 (ref. 27)) and 
the analytical range was 0.694–55.52 nmol l − 1. The range of T in the sample 
(4–16.3 nmol l − 1) was lower than published reference ranges for young adult males 
(for example, 10.4–41.6 nmol l − 1 (ref. 28)). This is likely to be due to a negative bias 
and/or underestimation of T reported for the Immulite® platform29 and is unlikely 
to have influenced our assessment of inter-individual variation in T.
Cortisol. C levels were determined in the same laboratory using Immulite®  
2000 Cortisol, following the procedure described above27, for a subset of the 
sample (n = 62). Cortisol was not assessed for the remaining 12 participants due to 
insufficient quantities of remaining serum. In this case, the alkaline phosphatase-
labelled reagent was conjugated to C, and polystyrene beads were coated with poly-
clonal rabbit anti-C. Immulite® 2000 Cortisol quality control samples were included 
to assess assay reliability. Mean intra-assay CV was 6.6%, the method lower limit  
of detection was 27 nmol l − 1 (manufacturer’s standard: 5.5 nmol l − 1 (ref. 27)) and 
the analytical range was 28–1380 nmol l − 1. The range of C in the sample (205–
759 nmol l − 1) extended above published reference ranges (140–690 nmol l − 1)28, 
which is likely to be due to our collection of samples in the morning, which coin-
cides with a natural peak in the diurnal fluctuation of C30. 
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